Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer. Slater S, Cunningham D. Lancet 2023 Apr 14:S0140-6736(23)00767-5. doi: 10.1016/S0140-6736(23)00767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slater S, Cunningham D. Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer. Lancet 2023 Apr 14:S0140-6736(23)00767-5. doi: 10.1016/S0140-6736(23)00767.
PMID: 37075782